Overview Fundamentals API Earnings EOD API Sample Code Pricing

Odonate Therapeutics (ODTC PINK) stock market data APIs

$17100 0(0%) as of July 12, 2024
Price chart is built with Anychart

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.

Odonate Therapeutics Financial Data Overview

17100
17100
-
17100
17100
2849.5-25000
48 786 K
2 853
0
0
0.121
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ODTC',
Type: 'Common Stock',
Name: 'Odonate Therapeutics',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00J7CCMX6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1717452',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2017-12-07',
InternationalDomestic: NULL,
Sector: 'Financial Services',
Industry: 'Shell Companies',
HomeCategory: NULL,
IsDelisted: false,
}

Odonate Therapeutics Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -80 183 000
  • Earnings Per Share -30665.43
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Odonate Therapeutics Earnings via APIs

  • Latest Release 2023-11-09
  • EPS/Forecast 0

Get Odonate Therapeutics End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com